N-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide

C17H24BrNO3S — CID 78889350

IUPACN-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide
SMILESCC(C)(CNC(=O)CS(=O)(=O)C1CCCC1)c1ccc(Br)cc1
InChIInChI=1S/C17H24BrNO3S/c1-17(2,13-7-9-14(18)10-8-13)12-19-16(20)11-23(21,22)15-5-3-4-6-15/h7-10,15H,3-6,11-12H2,1-2H3,(H,19,20)
InChIKeyYPOBQZJMAWMLTQ-UHFFFAOYSA-N
MW402.35 g/mol
LogP3.20
Rot. Bonds6

About N-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide

N-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide (PubChem CID 78889350) has the molecular formula C17H24BrNO3S and a molecular weight of 402.35 g/mol. Its IUPAC name is N-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide.

Molecular Properties

Compound NameN-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide
PubChem CID78889350
Molecular FormulaC17H24BrNO3S
Molecular Weight402.35 g/mol
Exact Mass401.07
IUPAC NameN-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide
SMILESCC(C)(CNC(=O)CS(=O)(=O)C1CCCC1)c1ccc(Br)cc1
InChIInChI=1S/C17H24BrNO3S/c1-17(2,13-7-9-14(18)10-8-13)12-19-16(20)11-23(21,22)15-5-3-4-6-15/h7-10,15H,3-6,11-12H2,1-2H3,(H,19,20)
InChIKeyYPOBQZJMAWMLTQ-UHFFFAOYSA-N
XLogP3.20
TPSA63.24 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds6
Heavy Atoms23
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500402.35
LogP ≤ 53.20
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Analyze N-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[2-(4-bromophenyl)-2-methylpropyl]-2-pyrrolidin-2-ylacetamide;hydrochloride
CID 119733957
N-[2-(4-bromophenyl)-2-methylpropyl]-3-sulfanylpropanamide
CID 115168128
N-[2-(4-bromophenyl)-2-methylpropyl]pyrrolidine-2-carboxamide
CID 115159331
(2S)-N-[2-(4-bromophenyl)-2-methylpropyl]oxolane-2-carboxamide
CID 51948734
N-[2-(4-bromophenyl)-2-methylpropyl]-1-(hydroxymethyl)cyclopropane-1-carboxamide
CID 115182484
4-bromo-N'-(3-cyclopentylsulfonylpropanoyl)benzohydrazide
CID 78879611
4-bromo-N-[2-(4-chlorophenyl)-2-methylpropyl]benzamide
CID 113090383
3-[(2-cyclopentylsulfonylacetyl)amino]-2-methylpropanoic acid
CID 119237505
N-[2-methyl-2-(4-methylphenyl)propyl]-2-pyrrolidin-2-ylacetamide
CID 119775261
2-cyclopentylsulfonyl-N-[(4-hydroxypyrrolidin-3-yl)methyl]acetamide;hydrochloride
CID 120943963
2-[[N-[2-(4-bromophenyl)-2-methylpropyl]-N'-methylcarbamimidoyl]amino]-N-tert-butylacetamide
CID 111385018
2-amino-N-[2-(4-bromophenyl)-2-methylpropyl]-2-phenylacetamide
CID 119295146

Frequently Asked Questions

What is the IUPAC name of N-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide?
The IUPAC name of N-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide (CID 78889350) is N-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide.
What is the SMILES notation for N-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide?
The canonical SMILES for N-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide is CC(C)(CNC(=O)CS(=O)(=O)C1CCCC1)c1ccc(Br)cc1.
What is the InChIKey of N-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide?
The InChIKey is YPOBQZJMAWMLTQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H24BrNO3S/c1-17(2,13-7-9-14(18)10-8-13)12-19-16(20)11-23(21,22)15-5-3-4-6-15/h7-10,15H,3-6,11-12H2,1-2H3,(H,19,20).
What are the key properties of N-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide?
N-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide has a molecular weight of 402.35 g/mol, XLogP of 3.20, 6 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(4-bromophenyl)-2-methylpropyl]-2-cyclopentylsulfonylacetamide is sourced from PubChem (CID 78889350), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).